A multi-center Randomized Controlled Trial of superior formula of Jianpi Huayu Jiedu for gastric precancerous lesions
- Conditions
- Gastric Precancerous Lesion
- Registration Number
- ChiCTR2400088865
- Lead Sponsor
- Guangzhou University of Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Chronic atrophic gastritis was diagnosed by histopathology and conformed to the diagnostic criteria of traditional Chinese medicine; the age was = 18 years old and < 70 years old; all the HP positive patients had received anti-HP treatment and were enrolled in the HP negative group; those who had not received other treatment in the last month and did not participate in other new drug clinical trials; voluntarily signed informed consent form; passed the hospital ethics review.
Misdiagnosed as chronic atrophic gastritis; complicated with gastric ulcer, gastric hemorrhage, esophageal cancer and other digestive tract tumors; severe heart, brain, liver, kidney, lung and other diseases; major organ damage, dysfunction; complicated with hematological diseases, endocrine, tumors, autoimmune diseases; serious diseases need rescue, surgery and other treatment, can not continue this experiment; serious mental and nervous system diseases. People who are addicted to drugs such as aspirin and opiates; those who have bad habits such as alcoholism; those who need isolation treatment for severe infectious diseases; have contraindications or no history of drug allergy to useful drugs, are allergic to the drugs in this study; are pregnant or lactating; those who are positive for HP infection or are ineffective by anti-HP treatment; take proton pump inhibitors, H2 receptor antagonists, acid inhibitors, quinolones antibiotics or bismuth agents within one week. Experts from other research groups agree that it is not suitable for inclusion.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Histopathological evaluation;
- Secondary Outcome Measures
Name Time Method Efficacy of clinical symptoms;Criteria for judging the curative effect of TCM syndromes;